Urban N

No ORCID on file · 6 papers in corpus · active 2004-2016

Study types

  • article 1

Condition tags

  • endometriosis 1
  • infertility 1
article 2016
Reproduction (Cambridge, England) ·doi:10.1530/rep-16-0265

Infertility is a risk factor for ovarian cancer (OvCa). The goal was to determine if antibodies to selenium-binding protein 1 (SBP1), an autoantibody we identified in patients with premature ovarian failure (POF), occurs in both infertility…

2015
PloS one ·doi:10.1371/journal.pone.0121112

BackgroundLeucine-rich alpha-2-glycoprotein (LRG1) was found to be differentially expressed in sera from patients with Epithelial Ovarian Cancer (EOC). The aim of this study is to investigate the performance of LRG1 for detection of EOC, in…

2011
Journal of the National Cancer Institute ·doi:10.1093/jnci/djr359

In screening for epithelial ovarian cancer, unnecessary surgery can be reduced by limiting use of transvaginal ultrasound (TVU) to women with increasing CA125 serum levels. Replacing or augmenting TVU with measurement of a serum marker spec…

2008
Gynecologic Oncology ·doi:10.1016/j.ygyno.2008.07.036

ObjectivesTo define patterns of aberrant DNA methylation, p53 mutation and Her-2/neu overexpression in tissues from benign (n=29), malignant (n=100), and border line malignant ovaries (n=10), as compared to normal (n=68) ovarian tissues. Fu…

2007
Biomarkers in medicine ·doi:10.2217/17520363.1.4.513

A quarter of a century since its discovery, circulating CA125 antigen is recommended for clinical use in the USA for ovarian cancer screening of high-risk women with ovaries, despite its limited sensitivity and specificity. Recent findings …

2004
Gynecologic Oncology ·doi:10.1016/j.ygyno.2004.07.039

ObjectivesThe serum tumor marker CA 125 is elevated in most clinically advanced ovarian carcinomas. Because these elevations may precede clinical detection by a year or more, CA 125 is potentially useful for early detection as part of an ov…